18d
BridgeBio Pharma Investor Update: PROPEL 3 “Last Visit” Set as Infigratinib Phase 3 Readout Nears
BridgeBio Pharma (NASDAQ:BBIO) hosted an investor webinar to outline its clinical and commercial strategy for infigratinib, an oral FGFR inhibitor being developed for achondroplasia, ahead of an ...
Physicists have uncovered a link between magnetism and a mysterious phase of matter called the pseudogap, which appears in ...
The Brighterside of News on MSN
A new type of microscope lets scientists observe life unfolding inside cells
A new kind of microscope is giving scientists a way to watch life inside cells with a clarity that feels almost unfair. Instead of choosing between seeing big structures or tiny particles, researchers ...
Bitcoin’s 31% drop ($126K to $87K) matches mid-cycle corrections: Falls within 25-40% range typical of bull market resets. Historical recovery timelines suggest 3-6 month consolidation. The current ...
Smith, C.A. and Pramanik, S. (2026) A Pilot Study on How Microplastic Polluted Rainfall Infiltrates Commonly Eaten Leafy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results